The Study
APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia
This study found that people with a certain gene version (APOE4/4) tend to have more fatty blobs in their brain cleanup cells when they have Alzheimer’s. But it doesn’t prove that the gene makes the blobs — maybe the disease makes both the gene and the blobs appear together. It’s like noticing people who wear raincoats often carry umbrellas — one doesn’t cause the other, they just show up together.
Analysis score
Maximum 58 for a case-control study.
Where the score came from
In Alzheimer’s, brain cleanup cells called microglia get clogged with fat when someone has the APOE4 gene. These fat-clogged cells then leak toxic stuff that damages brain cells and makes Alzheimer’s symptoms worse.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 554 / 100
Quality score
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this means people with two copies of APOE4 are more likely to develop severe Alzheimer’s because their brain cells become toxic fat factories that poison nearby neurons.
- 2APOE4/4 microglia had 2–3x more lipid droplets than APOE3/3 after Aβ exposure; conditioned media from lipid-rich microglia caused 3x more tau phosphorylation and 4x more neuron death than from clean microglia.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Nature
Year
2024
Authors
Michael Haney, Róbert Pálovics, Christy N Munson, Chris M. Long, Patrik K. Johansson, Oscar Yip, Wentao Dong, E. Rawat, Elizabeth West, J. Schlachetzki, A. Tsai, Ian H. Guldner, B. S. Lamichhane, Amanda Smith, N. Schaum, K. Calcuttawala, Andrew Shin, Yung-Hua Wang, Chengzhong Wang, Nicole Koutsodendris, G. Serrano, T. Beach, E. Reiman, Christopher K. Glass, Monther Abu-Remaileh, Annika Enejder, Yadong Huang, T. Wyss‐Coray
Related Content
Claims (6)
Microglia filled with lipids release molecules that cause Tau protein to become abnormally phosphorylated and trigger death of human neurons, a process dependent on the APOE gene and directly linked to Alzheimer’s disease neurodegeneration.
Blocking the PI3K protein in human microglia cells exposed to amyloid-beta decreases lipid droplet buildup and inflammation while increasing the production of neuroprotective molecules.
Fibrillar amyloid-beta triggers increased triglyceride production and lipid droplet formation in human microglia, and this effect is stronger in microglia carrying two copies of the APOE4 gene variant compared to those with two copies of the APOE3 gene variant.
In Alzheimer’s disease, human brain immune cells with the APOE4 gene variant accumulate more triglyceride-rich lipid droplets when exposed to amyloid-beta, and these lipids are passed to nearby neurons, disrupting their lipid balance.
People with Alzheimer’s disease who have two copies of the APOE4 gene variant have more microglia filled with lipid droplets and expressing ACSL1 than those with two copies of the APOE3 gene or people without Alzheimer’s disease.
The APOE4 allele is associated with reduced clearance of amyloid-beta, increased accumulation of tau protein, damage to the blood-brain barrier, altered lipid processing in microglia, and decreased function of the glymphatic system.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.